Medical/Pharmaceuticals
Juniper Biologics Pte. Ltd. signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
LUGANO, Switzerland, Sept. 1, 2022 /PRNewswire/ -- Helsinn Group ("Helsinn"), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and Juniper Biologics Pte Ltd, a science-led healthcare company foc...
2022-09-01 17:00
1737
"Blue Pea Flower and Banana Stem Extract" Drink to Reduce the Risk of Urinary Stone - Another Medical Innovation from Chula MED
BANGKOK, Sept. 1, 2022 /PRNewswire/ -- Urinary tract stone is common among
people of the tropics such asThailand. In 2020, surveys show that 16-17 percent
of the population have this disease, and up to 12 percent of the patients have
an asymptomatic urinary stone.
2022-09-01 13:11
2510
Antengene Announces XPOVIO® Included for Reimbursement by the PBS in Australia for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma
* XPOVIO® (selinexor) is the first and only selective inhibitor of nuclear export (SINE) inhibitor approved by the Therapeutic Goods Administration (TGA) ofAustralia for patients with relapsed and/or refractory multiple myeloma (R/R MM) and intriple class refractory R/R MM. * XPOVIO® is the f...
2022-09-01 08:30
2382
Breast Cancer AI Company FathomX Raises SGD$ 2.24 million in Pre-series A Funding
SINGAPORE, Sept. 1, 2022 /PRNewswire/ -- Singapore-based digital health AI company FathomX, a spin-off company from theNational University of Singapore (NUS) andNational University Health System (NUHS), recently raised a Pre-series A fund of SGD$ 2.24 million in the lead up to Series A funding. ...
2022-09-01 08:30
3106
Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum
Addition increases diversity of Board governance and supports further
independent expertise
DURHAM, N.C. and BEIJING, Sept. 1, 2022 /PRNewswire/ -- Brii Biosciences
2022-09-01 07:30
2459
Broncus (02216.HK) announced interim results
The operating revenue had a year-on-year increase by 12.8% in 2022, and the loss narrowed by 62.8%, gradually forming a closed-loop model of "diagnosis + treatment+ chronic disease management" for major pulmonary diseases HANGZHOU, China, Aug. 31, 2022 /PRNewswire/ -- On August 30, 2022, Broncus ...
2022-08-31 22:04
4185
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
ROCHESTER, Minn. and ROCKVILLE, Md., Aug. 31, 2022 /PRNewswire/ -- Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet pat...
2022-08-31 21:00
2425
Quris Earns Frost & Sullivan 2022 Europe Technology Innovation Leadership Award for AI-Powered Drug Safety Prediction
Analysts found that the Quris Bio-AI Clinical Prediction Platform enhances drug development process agility, shortens discovery timelines, increases drug safety, and improves drug pipeline diversification opportunities SAN ANTONIO, Aug. 31, 2022 /PRNewswire/ -- Frost & Sullivan recently research...
2022-08-31 20:00
2465
TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS
VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the medical potential of the body's ability to self-repair and regenerate, today announced the publication in Frontiers in Phamacology of peer-reviewed research supporting the unique broad spec...
2022-08-31 15:29
1477
NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421
TAIPEI, Aug. 31, 2022 /PRNewswire/ -- United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of NIH. The purpose of this study is to asses...
2022-08-31 12:24
1686
NuraLogix researchers announce AI models that can predict Blood Biomarker Risk
TORONTO, Aug. 31, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of HbA1C levels and Fasting Blood Glucose levels being above a significant clinical threshold for pre-diabetes....
2022-08-31 11:32
1957
Antengene Announces Interim 2022 Financial Results and Provides Corporate Update
- Revenue of RMB 53.96 million mainly driven by the commercial launch of XPOVIO® (selinexor) in Mainland China onMay 13, 2022 - Adjusted loss reduced to RMB 126 million for the first six months of 2022 fromRMB 210 million in the same period last year - Cash and bank balances of RMB 2.151 billion...
2022-08-31 08:29
2480
Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area
NANNING, China, Aug. 31, 2022 /PRNewswire/ -- Recently, the lung CT image-aided diagnosis software developed by Guangxi Yizhun Intelligent Technology Co., Ltd. ("Yizhun") in National Nanning Economic & Technological Development Area ("Area") has been granted the registration certificate of class ...
2022-08-31 00:32
2256
ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare
The fully connected environment, digital technologies and artificial intelligence tools enable optimization of patient care. JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ -- ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advanc...
2022-08-30 22:00
2366
LifeTech Scientific Corporation (1302.HK) Announces 2022 Interim Results
* Revenue increased by 20.4%, net profit attributable to owners of the Company increased by 34.4% after excluding certain non-recurring items SHENZHEN, China, Aug. 30, 2022 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally ...
2022-08-30 21:45
3767
Optina Diagnostics Earns Frost & Sullivan's 2022 North American Technology Innovation Leadership Award for Leveraging Innovative Eye Imagery and Artificial Intelligence for Chronic Diseases Detection including Alzheimer's
Optina Diagnostics' solutions enable specialists and primary care physicians to diagnose chronic diseases including Alzheimer's with reliable and precise retinal scans. SAN ANTONIO, Aug. 30, 2022 /PRNewswire/ -- Based on its recent analysis of the North American Hyperspectral Retinal Imaging Ind...
2022-08-30 20:00
2241
VitalLife Achieves GHA's Certification for Excellence in Medical Travel Patient Experience
PALM BEACH GARDENS, Fla., Aug. 30, 2022 /PRNewswire/ -- VitalLife Scientific
Wellness Center in Bangkok, Thailand has achieved Certification for Excellence
in Medical Travel Patient Experience byGlobal Healthcare Accreditation (GHA).
2022-08-30 18:00
1926
'Medlab Asia & Asia Health 2022' to Promote Thailand as a Medical Hub of ASEAN by Collaborating with Department of Health Service Support and Medical Industry
BANGKOK, Aug. 30, 2022 /PRNewswire/ -- 'Medlab Asia & Asia Health 2022' is the leading medical event in the ASEAN region which is all set to run in Thailand for the first time, co-hosted by IMPACT Exhibition Management and Informa Markets, and supported by Department of Health Service Support, Mi...
2022-08-30 15:35
2063
Baxter Hosts 2022 Digital Surgery Summit: Reimagining Connected Surgery
Inspiring surgical innovation for patient care based on connectivity
SINGAPORE, Aug. 30, 2022 /PRNewswire/ -- Baxter International Inc.
2022-08-30 10:10
2284
New report highlights the technology key to fighting future pandemics
MELBOURNE, Australia, Aug. 30, 2022 /PRNewswire/ -- CSIRO, Australia's national science agency, has outlined the science and technology that can help improve resilience to future pandemics, reduce their economic impact and protect communities. The Strengthening Australia's Pandemic Preparedness ...
2022-08-30 04:00
2742
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7877
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6967
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4260
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2910